UCSF Foundation Investment Company is a financial services company
Established in 2015, the UCSF Foundation Investment Company provides professional stewardship of the UCSF Foundation’s financial assets and an endowment now valued at more than $1.5 billion. The endowment facilitates UCSF’s work in education, scientific research, patient care, and public health. The non-profit UCSF Investment Company is led by its chief investment officer and governed by the Investment Company Board, which comprises selected volunteer leaders from the UCSF Board of Overseers as well as external investment and business experts.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 17, 2022
Rezo Therapeutics
|
Series A | $78M | Biotechnology | — |
Oct 27, 2022
Hazel Health
|
Series C | $51.50M | Education | — |